Skip to main content
. Author manuscript; available in PMC: 2022 Jun 24.
Published in final edited form as: J Nat Prod. 2020 Nov 23;84(3):750–761. doi: 10.1021/acs.jnatprod.0c00946

Figure 9.

Figure 9.

Concentration–response curves for cepharanthine, tetrandrine (16), and dauisolide (17) in triple-negative breast cancer (HCC1937, HCC1806, HCC70, MDA-MB-231, and MDA-MB-453) and pediatric cancer cell lines (Ewing sarcoma, A-673; rhabdomyosarcoma, SJCRH30). Data represent the mean of 3 or 4 experiments, ±SEM.